Evidence map›Paper›PMID 29463545›Full record

ArticleAntimicrobial agents and chemotherapy2018

Detection of TR

Elizabeth L Berkow, Natalie S Nunnally, Alex Bandea, Randall Kuykendall, Karlyn Beer, Shawn R Lockhart

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 52 citations in OpenAlex.

  1. Global epidemiology of azole resistance inJAC-antimicrobial resistance · 2026
    Review
  2. Investigation of azole resistance inJournal of medical microbiology · 2026
    Article
  3. Article
  4. Azole-ResistantJournal of fungi (Basel, Switzerland) · 2025
    Review
  5. Article
  6. Review
  7. Triazole resistance inApplied and environmental microbiology · 2024
    Article
  8. Review
  9. Trends in the activity of mold-active azole agents againstJournal of clinical microbiology · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Studies in mycology · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Elizabeth L BerkowMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Natalie S NunnallyMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Alex BandeaMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Randall KuykendallMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Karlyn BeerMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Shawn R LockhartMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA gyi2@cdc.gov.
Centers for Disease Control and Prevention · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of azole-resistant

Indexed as

Antifungal AgentsAspergillus fumigatusAzolesDrug Resistance, FungalFungal ProteinsGenotypeHumansMicrobial Sensitivity TestsMutationUnited StatesAntifungal AgentsAzolesFungal ProteinsAspergillus fumigatusazole resistanceCYP51A mutationTR34/L98HTR46/Y121F/T289A

Identifiers

PMID29463545
PMCPMC5923109
OpenAlexW2790411649

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.